AVDL Projected Dividend Yield
Ord/Avadel Pharmaceuticals PLC ( NASDAQ : AVDL )Avadel Pharmaceuticals PLC is a biopharmaceutical company. Co.'s lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and MEDUSA. Its MICROPUMP technology allows for the development of modified release solid, oral dosage formulations of drugs. 21 YEAR PERFORMANCE RESULTS |
AVDL Dividend History Detail AVDL Dividend News AVDL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |